A group of researchers from the Sanford-Burnham Medical Research Institute in Orlando, FL, have found an RNA biomarker detectable in prostate cancer patients’ urine and tissue samples. There is an unmet need to develop efficient, sensitive and specific biomarkers that allow for an early detection of prostate cancer, this way reducing overtreatment and associated mortality.